Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Resources topic

No spam. Unsubscribe anytime.

Forum points attendees to GDUFA 3 resources; Dr. Zink introduced as next presenter

Generic Drugs Forum (Office of Generic Drugs) · July 30, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The presenter listed guidance documents and a recorded presentation covering changes implemented with GDUFA 3 and introduced Dr. Zink of the Office of Bioequivalence as the next speaker.

At the end of the session the presenter pointed attendees to reference materials including published guidances and a previously recorded presentation on changes implemented with GDUFA 3: “The guidances are listed here. Generic drug user fee authorization or commitment letter that, identifies what we've committed to do as far as, deadlines are concerned. The guidance for covered product authorization.”

She then introduced the next speaker: “I now welcome Doctor. Zink from the Office of Bioequivalent.” The presenter did not read Dr. Zink's title beyond the office name; the transcript records the introduction but not Dr. Zink's remarks in this excerpt.